Skip to content
EnLiSense LLC logo — EnLiSense biosensors and platform technologies enables track...

EnLiSense LLC

EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to WELLNESS states

Founded 2014 United States Allen, United States 7 employees Grant Health Care, Manufacturing

General Information

Company Name EnLiSense LLC
Founded Year 2014
Location United States Allen, United States
Employees 7
Industries Health Care, Manufacturing
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with EnLiSense LLC. To contact EnLiSense LLC, visit enlisense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EnLiSense LLC compare?

A PDF of EnLiSense LLC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EnLiSense LLC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EnLiSense LLC

EnLiSense LLC, a sensor device company founded in 2014, is making strides in the health care and manufacturing industries. The company's slogan, "EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to WELLNESS states," encapsulates its core mission. EnLiSense specializes in providing innovative biosensing solutions for portable and wearable diagnostic devices. Its current portfolio encompasses non-invasive detection of blood glucose, stress, and inflammatory biomarkers in sweat, as well as the detection and quantification of multiple biomarkers of cardiovascular diseases in small volumes of whole blood. These easy-to-use, reliable, and cost-effective technologies hold promise for diagnostic and prognostic testing of chronic and infectious diseases in home, point-of-care, and ambulatory environments. The last investment in EnLiSense LLC took place on 21 March 2023, with the Crohn's & Colitis Foundation demonstrating confidence in the company's potential. As EnLiSense continues to pioneer advances in biosensing technologies, its emphasis on wellness tracking and diagnostic solutions positions it as a compelling venture capital opportunity in the rapidly evolving health care landscape.

Business keywords: biosensor technology, wearable diagnostic devices, consumer healthcare, blood glucose monitoring, stress biomarkers, inflammatory biomarkers, cardiovascular disease, chronic disease testing, infectious disease testing, point-of-care diagnostics, ambulatory diagnostics, non-invasive detection, sweat biomarkers, whole blood testing, prognostic testing

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Crohn's & Colitis Foundation
21 Mar 2023

EnLiSense LLC Alternatives & Competitors

View All Alternatives
EnLiSense LLC vs
i-SENS, Inc.
i-SENS, Inc. Korea South

i-SENS is a global company dedicated to improving the lives of people with diabetes and those who ca...

Series A
106 employees
Health Care, Manufacturing
EnLiSense LLC vs

Kisshealth Biotechnology Co., Ltd., automatic solution provider of in vitro pathological diagnosis a...

Angel
2 employees
Health Care, Manufacturing
EnLiSense LLC vs
SunTech
SunTech United States

Clinical-Grade Non-Invasive Blood Pressure Technology and Medical Devices

107 employees
Health Care, Manufacturing

FAQ About EnLiSense LLC

EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to WELLNESS states
EnLiSense LLC was founded in 2014.
EnLiSense LLC is headquartered in Allen, United States.
EnLiSense LLC operates in Health Care and Manufacturing. Its work centres on biosensor technology, wearable diagnostic devices, consumer healthcare and blood glucose monitoring.
EnLiSense LLC has approximately 7 employees.
EnLiSense LLC has completed 1 funding round. The latest funding stage is Grant.
Top alternatives and competitors to EnLiSense LLC include i-SENS, Inc. , KISSH, SunTech, True Diagnostics™, AgaMatrix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EnLiSense LLC and i-SENS, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EnLiSense LLC, https://bouncewatch.com/company/enlisense-llc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout